Maternal Mirtazapine Selectively Enhances Hippocampal LTP without
                    Reversing Stress-Associated Alterations in Basal Transmission, Short-Term
                    Plasticity, or Open Field Behaviour in Rat Offspring

Zdenka Gasparova; Stanislava Bukatova; Michal Dubovicky

doi:10.1055/a-2682-5112

Drug Research, Inhaltsverzeichnis

Drug Res (Stuttg)
DOI: 10.1055/a-2682-5112

Original Article

Maternal Mirtazapine Selectively Enhances Hippocampal LTP without Reversing Stress-Associated Alterations in Basal Transmission, Short-Term Plasticity, or Open Field Behaviour in Rat Offspring

Authors

Zdenka Gasparova

¹Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
Stanislava Bukatova

¹Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
Michal Dubovicky

¹Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic

Abstract

Introduction

Maternal stress during pregnancy has profound effects on offspring, disrupting brain development and behaviour. Mirtazapine, an antidepressant commonly prescribed for maternal depression, has an unclear impact on offspring neurophysiology and behaviour. We hypothesized that maternal mirtazapine treatment during pregnancy and lactation would influence locomotor activity, exploratory behaviour, and hippocampal synaptic plasticity in rat offspring, particularly in the context pre-gestational stress.

Methods

Offspring from control or chronically stressed dams, treated with either vehicle or mirtazapine, were assessed. Behavioural responses were evaluated using the open field test, and the hippocampus was examined electrophysiologically to measure population spike (PS) amplitude of compound action potential, field excitatory postsynaptic potential (fEPSP) slope, short-term plasticity, and long-term potentiation (LTP).

Results

Maternal stress significantly reduced exploration of the central zone, indicating increased anxiety-like behaviour, although post hoc comparisons did not reach significance. Mirtazapine treatment did not reverse these behavioural alterations. PS amplitude was unaffected across groups, but fEPSP slope was significantly reduced in stressed offspring, with no recovery observed following mirtazapine treatment. Paired-pulse ratios across inter-pulse intervals (10–100 ms) were consistently decreased in the stressed group, indicating impaired short-term synaptic plasticity, which mirtazapine did not restore. In contrast, LTP showed a significant stress×treatment interaction (p=0.0201), suggesting that mirtazapine selectively enhanced long-term plasticity in stressed offspring.

Discussion and Conclusion

Mirtazapine did not reverse behavioural impairments or basal synaptic transmission deficits induced by maternal stress. It may selectively enhance long-term synaptic plasticity, suggesting its potential to modulate specific neurodevelopmental outcomes following prenatal stress exposure.

Key words

antidepressant drugs - anxiolytic drugs - behavioural pharmacology - psychiatric disorders - drug research

Volltext

Referenzen

References
1 Cohen LS, Altshuler LL, Harlow BL. et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295: 499-507
2 MacQueen GM, Frey BN, Ismail Z. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 6. Special populations: youth, women, and the elderly. Can J Psychiatry 2016; 61: 588-603
3 McAllister Williams RH, Baldwin DS, Cantwell R. et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum. J Psychopharmacol 2017; 31: 519-552
4 Cantarutti A, Merlino L, Giaquinto C. et al. Use of antidepressant medication in pregnancy and adverse neonatal outcomes: a population-based investigation. Pharmacoepidemiol Drug Saf 2017; 26: 1100-1108
5 Steiner M. Prenatal exposure to antidepressants: how safe are they?. Am J Psychiatry 2012; 169: 1130-1132
6 Yonkers KA, Wisner KL, Stewart DE. et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 2009; 31: 403-413
7 Alder J, Fink N, Bitzer J. et al. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007; 20: 189-209
8 Chen LF, Lin CE, Chung CH. et al. Association between the use of antidepressants and the risk of preterm birth among pregnant women with depression: a retrospective cohort study in Taiwan. J Invest Med 2021; 69: 999-1007
9 Su JA, Chang CC, Yang YH. et al. Neonatal and pregnancy complications following maternal depression or antidepressant exposure: A population-based, retrospective birth cohort study. Asian J Psychiat 2023; 84: 103545
10 Bénard-Laribière A, Pambrun E, Sutter-Dallay AL. et al. Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study. Br J Clin Pharmacol 2018; 84: 1764-1775
11 Molenaar NM, Kamperman AM, Boyce P. et al. Guidelines on treatment of perinatal depression with antidepressants: An international review. Aust N Z J Psychiatry 2018; 52: 320-327
12 Marchocki Z, Russell NE, O’Donoghue K. Selective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits. Obstet Med 2013; 6: 155-158
13 Holland J, Brown R. Neonatal venlafaxine discontinuation syndrome: A mini-review. Eur J Paediatr Neurol 2017; 21: 264-268
14 Ankarfeldt MZ, Petersen J, Andersen JT. et al. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden. PLoS Med 2021; 18: e1003851
15 Gallitelli V, Franco R, Guidi S. et al. Depression treatment in pregnancy: Is it safe, or is it not?. Int J Environ Res Public Health 2024; 21: 404
16 Anders M, Kitzlerová E. Mirtazapinum. Remedia 2004; 14: 386-397
17 Alam A, Voronovich Z, Carley JA. A review of therapeutic uses of mirtazapine in psychiatric and medical conditions. Prim Care Companion CNS Disord 2013; 15: PCC.13r01525
18 Thompson C. Mirtazapine versus selective serotonin reuptake inhibitors. J Clin Psychiatry 1999; 60: 18-22
19 Mokhtari T, Tu Y, Hu L. Involvement of the hippocampus in chronic pain and depression. Brain Sci Adv 2019; 5: 288-298
20 Mandl S, Alexopoulos J, Doering S. et al. The effect of prenatal maternal distress on offspring brain development: A systematic review. Early Hum Dev 2024; 192: 106009
21 Ivy AS, Brunson KL, Sandman C. et al. Dysfunctional nurturing behavior in rat dams with limited access to nesting material: a clinically relevant model for early-life stress. Neuroscience 2008; 154: 1132-1142
22 Creutzberg KC, Kestering-Ferreira E, Wendt Viola T. et al. Corticotropin-releasing factor infusion in the bed nucleus of the stria terminalis of lactating mice alters maternal care and induces behavioural phenotypes in offspring. Sci Rep 2020; 10: 19985
23 van Hasselt FN, Tieskens JM, Trezza V. et al. Within-litter variation in maternal care received by individual pups correlates with adolescent social play behavior in male rats. Physiol Behav 2012; 106: 701-706
24 Maková M, Kašparová S, Bačiak L. et al. Effects of maternal depression and antidepressant treatment on neurotransmitters, brain regions, and mitochondrial function in rat dams. Neurochem Int 2025; 187: 105981
25 Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659-661
26 Viñas-Noguera M, Csatlosova K, Simoncicova E. et al. Sex- and age-dependent effect of pregestational chronic stress and mirtazapine treatment on neurobehavioral development of Wistar rat offspring. PLoS ONE 2022; 17: e0255546
27 Gasparova Z, Stara V, Stolc S. Effect of antioxidants on functional recovery after in vitro-induced ischemia and long-term potentiation recorded in the pyramidal layer of the CA1 area of rat hippocampus. Gen Physiol Biophys 2014; 33: 43-52
28 Hallberg P, Sjöblom V. The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol 2005; 25: 59-73
29 Laine K, Heikkinen T, Ekblad U. et al. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60: 720-726
30 Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004; 113: 368-375
31 Klier CM, Mossaheb N, Lee A. et al. Mirtazapine and breastfeeding: maternal and infant plasma levels. Am J Psychiatry 2007; 164: 348-349
32 Dubiel-Hoppanová J, Filipová A, Bukátová S. et al. Pregestational stress representing a maternal depression model and prenatally applied antidepressant mirtazapine modulate hippocampal excitability in offspring. Sci Pharm 2025; 93: 17
33 Sahoo J, Pattnaik AK, Mishra N. Behavioral and developmental changes in rat with prenatal exposure of mirtazapine. Sci Pharm 2010; 78: 451-463
34 Maková M, Kašparová S, Tvrdík T. et al. Mirtazapine modulates Glutamate and GABA levels in the animal model of maternal depression. MRI and ¹H MRS study in female rats. Behav Brain Res 2023; 442: 114296
35 Willner P. The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol Stress 2017; 6: 78-93
36 Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci Biobehav Rev 1992; 16: 525-534
37 Belovicova K, Bogi E, Koprdova R. et al. Effects of venlafaxine and chronic unpredictable stress on behavior and hippocampal neurogenesis of rat dams. Neuro Endocrinol Lett 2017; 38: 19-26
38 Grinchii D, Janáková Csatlósová K, Viñas-Noguera M. et al. Effects of pre-gestational exposure to the stressors and perinatal bupropion administration on the firing activity of serotonergic neurons and anxiety-like behavior in rats. Behav Brain Res 2024; 459: 114796
39 Weinstock M. The long-term behavioural consequences of prenatal stress. Neurosci Biobehav Rev 2008; 32: 1073-1086
40 Brunton PJ, Russell JA. Prenatal social stress in the rat programmes neuroendocrine and behavioural responses to stress in the adult offspring: sex-specific effects. J Neuroendocrinol 2011; 22: 258-271
41 Barbar Shemirani S, Nasiri Khalili MA, Mahdavi SM. et al. The effect of mirtazapine on reducing chronic stress in male rats. Clin Neurosci J 2022; 9: e21
42 Rayen I, van den Hove DL, Prickaerts J. et al. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 2011; 6: e24003
43 Millard SJ, Lum JS, Fernandez F. et al. Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: a comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression. J Psychopharmacol 2019; 33: 230-243
44 Boulle F, Pawluski JL, Homberg JR. et al. Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring. Dev Psychobiol 2016; 58: 427-438
45 Sha Z, Xu J, Li N. et al. Regulatory molecules of synaptic plasticity in anxiety disorder. J Gen Med 2023; 16: 2877-2886
46 Tomar A, McHugh T. The impact of stress on the hippocampal spatial code. Trends Neurosci 2022; 45: 120-132
47 Abdallah CG, Jiang L, De Feyter HM. et al. Glutamate metabolism in major depressive disorder. Am J Psychiatry 2014; 171: 1320-1327
48 Duman RS, Aghajanian GK, Sanacora G. et al. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 2016; 22: 238-249
49 Luján R, Shigemoto R, López-Bendito G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 2005; 130: 567-580
50 Huang Y, Shen Z, Hu L. et al. Exposure of mother rats to chronic unpredictable stress before pregnancy alters the metabolism of gamma-aminobutyric acid and glutamate in the right hippocampus of offspring in early adolescence in a sexually dimorphic manner. Psychiatry Res 2016; 246: 236-245
51 Bogi E, Belovicova K, Moravcikova L. et al. Pre-gestational stress impacts excitability of hippocampal cells in vitro and is associated with neurobehavioral alterations during adulthood. Behav Brain Res 2019; 375: 112-131
52 Maccari S, Krugers HJ, Morley-Fletcher S. et al. The consequences of early-life adversity: neurobiological, behavioural and epigenetic adaptations. J Neuroendocrinol 2014; 26: 707-723
53 Brunson KL, Eghbal-Ahmadi M, Bender R. et al. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci 2001; 98: 8856-8861
54 Reeves TM, Kao CQ, Phillips LL. et al. Presynaptic excitability changes following traumatic brain injury in the rat. J Neurosci Res 2000; 60: 370-379
55 Potier B, Billard JM, Riviere S. et al. Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats. Aging Cell 2010; 9: 722-735
56 Vazquez-Juarez E, Srivastava I, Lindskog M. The effect of ketamine on synaptic mistuning induced by impaired glutamate reuptake. Neuropsychopharmacology 2023; 48: 1859-1868
57 Kamal A, Ramakers GM, Altinbilek B. et al. Social isolation stress reduces hippocampal long-term potentiation: effect of animal strain and involvement of glucocorticoid receptors. Neurosci 2014; 256: 262-270
58 Korz V, Frey JU. Stress-related modulation of hippocampal long-term potentiation in rats: involvement of adrenal steroid receptors. J Neurosci 2003; 23: 7281-7287
59 Popoli M, Yan Z, McEwen BS. et al. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 2012; 13: 22-37
60 Citri A, Malenka RC. Synaptic plasticity: multiple forms, functions and mechanisms. Neuropsychopharmacol Rev 2008; 33: 18-41
61 Lissemore JI, Mulsant BH, Rajji TK. et al. Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy. J Psychiatry Neurosci 2021; 46: E88-E96
62 Pawluski JL, Gemmel M. Perinatal SSRI medications and offspring hippocampal plasticity: interaction with maternal stress and sex. Hormones (Athens) 2018; 17: 15-24
63 Cooke JD, Cavender HM, Lima HK. et al. Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus. Psychopharmacology (Berl) 2014; 231: 4429-4441
64 Kim JJ, Diamond DM. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 2002; 3: 453-462
65 Alfarez DN, Joëls M, Krugers HJ. Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur J Neurosci 2003; 17: 1928-1934
66 Weinstock M. Changes induced by prenatal stress in behavior and brain morphology: can they be prevented or reversed?. Adv Neurobiol 2015; 10: 3-25
67 Swant J, Chirwa S, Stanwood G. et al. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 Region of mouse hippocampus. PLoS ONE 2010; 5: e11382